The Miami Entrepreneur

Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs

Read Time:8 Second

Fast-approaching patent expirations will take a bite out of revenues and put the industry’s top players in the hot seat over the next few years.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post High Interest Rates Crushed Startup Investment. Here Is What Could Revive It.
Next post Bitbot picks momentum as Avalanche leads altcoin recovery